Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
BMC Research Notes|July 27, 2024
Sociodemographic influences on private and professional contact behaviour during the COVID-19 pandemic in Germany: cross-sectional analysis based on a Regional Blood Donor CohortRobert Pohl, Christoph Stallmann, Pauline Marquardt, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosisDirk Reinhold, Ute Bank, Michael Täger, et al.
International Immunopharmacology|December 13, 2006
Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammationDirk Reinhold, Aliza Biton, Stefanie Pieper, et al.
Frontiers in Cellular and Infection Microbiology|July 7, 2017
Behavior of Neutrophil Granulocytes during Toxoplasma gondii Infection in the Central Nervous SystemAindrila Biswas, Timothy French, Henning P Düsedau, et al.
Biomedicines|August 26, 2022
Characterization of Maladaptive Processes in Acute, Chronic and Remission Phases of Experimental Colitis in C57BL/6 MiceElif Gelmez, Konrad Lehr, Olivia Kershaw, et al.
European Journal of Immunology|February 12, 2020
IL-7 derived from lymph node fibroblastic reticular cells is dispensable for naive T cell homeostasis but crucial for central memory T cell survivalLaura Knop, Katrin Deiser, Ute Bank, et al.
Journal of Neuroinflammation|March 1, 2012
Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemiaPeter Röhnert, Werner Schmidt, Patrick Emmerlich, et al.
Biological Chemistry|January 4, 2011
Outside or inside: role of the subcellular localization of DP4-like enzymes for substrate conversion and inhibitor effectsUte Bank, Anke Heimburg, Astrid Wohlfarth, et al.
Annals of the New York Academy of Sciences|October 4, 2007
Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responsesDirk Reinhold, Aliza Biton, Alexander Goihl, et al.
International Immunopharmacology|December 13, 2006
Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel diseaseUte Bank, Anke Heimburg, Martin Helmuth, et al.
Pageof 3